Stock info Petmed Express | Filter  Basic-Info

Petmed Express

Petmed Express is mostly active in the pharmaceutical sector. Over the past 10 years the global pharmaceutical companies gained around 75 percent. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-December 2016) there is a minus of 75 percent.

The past year was a relatively good year for Petmed Express investors

The period between December 2015 and December 2016 was a good period for the investors. The stock gained almost 36 percent. The period between August 2011 and August 2016 was a good period for the investors. The stock rose around 133 percent. Petmed Express's revenues between 2011 and 2015 were relatively stable and moved between 238,25 million dollars and 229,4 million dollars. Petmed Express's net results between 2011 and 2015 were relatively stable and moved between 20,87 million dollars and 17,45 million dollars.

The American company paid out dividends in the past 5 years. On average the Petmed Express stock yielded a delivered a dividend yield of around 2,95 percent over the past 5 years.

Quite a lot of debt Petmed Express

At the end of 2015 the American company's balance sheet was worth 82,85 million dollars. At the end of 2015 the total debt positon equaled 7,41 million dollars. This is around 8,94 percent of the total balance sheet. Last year the pharmaceutical company's price/earnings-ratio (PE) was around 15. So the investors valued the stock at 15 times 2015' earnings per share. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.

At the end of 2015 the pharmaceutical company's market size (her number of outstanding share times the stock price) equaled around 337,45 million dollars. At the end of 2015 the American company had around 20,02 million stocks listed on the exchanges.

On this page you can find all Petmed Express's financial reports. More information about Petmed Express can be found it's website. .